• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) STYLE 110 SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) STYLE 110 SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Catalog Number 110-240
Medical Device Problem Code Device Appears to Trigger Rejection (1524)
Health Effect - Clinical Code Capsular Contracture (1761)
Date of Event 05/15/2023
Type of Reportable Event Serious Injury
Event or Problem Description
Patient reported left side ¿capsular contracture(grade is unknown)¿.Healthcare professional reported left side capsular contracture baker grade iii.Device was explanted.
 
Additional Manufacturer Narrative
A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: capsular contracture baker grade iii.
 
Additional Manufacturer Narrative
Device evaluation based on the device analysis grid, the assessments of the complaint are: capsular contracture: unable to observe since it is not related to the device.Additional observations: wear abrasion, crease fold and deformation device observed on the device.Brown particles observed on the device.
 
Event or Problem Description
Patient reported left side ¿capsular contracture(grade is unknown)¿.Healthcare professional reported left side capsular contracture baker grade iii.Device was explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STYLE 110 SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
Manufacturer Contact
terry ingram
12331-a riata trace parkway
building 3
austin, TX 78727
8479366324
MDR Report Key17440609
Report Number9617229-2023-12499
Device Sequence Number19465592
Product Code FTR
UDI-Device Identifier10888628002203
UDI-Public10888628002203
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
P020056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2023
Reporter Type Manufacturer
Report Source Foreign,Consumer,Health Professional
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 10/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/29/2020
Device Catalogue Number110-240
Device Lot Number2734870
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/11/2023
Supplement Date Received by Manufacturer10/10/2023
Initial Report FDA Received Date08/02/2023
Supplement Report FDA Received Date10/23/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/29/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age41 YR
Patient SexFemale
-
-